Introduction
Genetic and antigenic diversity is being recognised increasingly in Pneumocystis carinii [ 11. Gene sequencing and monoclonal antibody studies, particularly of the major surface glycoprotein, have identified differences between rat-and human-derived P carinii and between isolates from rats and human patients [2] . Recognition of these differences has made the use of rat antigen in human serology controversial and has overshadowed earlier studies which concluded that P carinii from rats and man have shared as well as distinct antigenic determinants [3, 41. In this laboratory, the results of 10 years' experience with rat-derived P carinii in an indirect immunofluorescence assay (IFA) for detection of IgG antibodies to I? carinii have consistently demonstrated that it can be useful [S-81 and the test is now offered as a Reference Service. Before rat-derived antigen is abandoned because of antigenic heterogeneity, it seems sensible to assess its diagnostic usefulness. useful test, but IgM and IgA testing and Trophozoites rather than cysts are associated with active P carinii infection [9] yet the potential value of trophozoites in serological diagnosis remains to be investigated. A previous study showed that the most useful serological marker of P carinii pneumonia (PCP) in immunosuppressed rats was demonstration of antibodies to proteins of 81 and 63 kDa present in trophozoite but not in cyst antigen preparations [lo] . The present study assessed the usefulness of immunoblotting with cyst and trophozoite rat-derived antigens in the serological diagnosis of human PCP.
Materials and methods

I? carinii antigens
PCP was induced in male Sprague-Dawley rats weighing 150 g (Harlan Olac, Bicester) by twiceweekly subcutaneous injection of 25 mg of hydrocortisone acetate (The Boots Company, Nottingham). Tetracycline ( 1 mg/ml) supplemented with penicillin (1 mg/ml) was added to the water supply provided for the rats to protect against bacterial infection. The rats were immunosuppressed for 6-8 weeks and developed auto-infection. They were killed by intraperitoneal injection of pentobarbitone sodium (Veterinary Drug Co., York). Giemsa, toluidine blue 0 and indirect immunofluorescence assay (IFA) with rat anti-I? carinii antiserum and fluorescein-conjugated anti-rat globulin (Dako, Denmark) were used to identie P carinii cysts and trophozoites in lung imprints, washings and gradient fractions [ 101.
The preparation of trophozoite-rich and cyst-rich fractions has been described previously [lo] . ll carinii was eluted from minced, heavily infected lung by repeated stirring for 30 min in sterile phosphatebuffered saline, pH 7.3, containing mixed antibiotics (PBSM). Eluates containing the most parasites and the least host cell contamination were washed three times in PBSM by centrifugation at 2000 g for 15 min and resuspended in PBSM containing 1 mM ethylene diamine tetra-acetic acid (EDTA). The suspensions were forced three times through a fine bore needle and gross particulate contamination was removed before digestion with collagenase (Type A; Sigma) 1.5 mg/ml at 37°C for 1.5 h with gentle agitation. Discontinuous gradients of three 5-ml layers of Percoll (Pharmacia) in PBSM containing 1 mM EDTA (density 36%, 16% and 8%, respectively) were loaded with 5 ml of sample and centrifuged at 2000 g for 15 min.
The interphases and intervening Percoll layers were collected individually from the top of the gradients by angled pipette, washed three times in PBSM and the relative numbers of cysts and trophozoites were counted. Fractions were classified according to the relative numbers of cysts and trophozoites and stored at -20°C. Fractions containing >go% trophozoites and >80% cysts were used in this study. Like fractions from the processed tissue of several animals were pooled to prepare sufficient antigen to test panels of sera. Fractions were pooled only when they had been examined individually by SDS-PAGE and immunoblotting with rat anti-ll carinii positive control serum and had given characteristic banding patterns as described previously [lo] . The antigen was distributed in aliquots and stored at -20°C until used for immunoblotting . 
Immunofuorescence assay
Serum antibodies were measured by an indirect immunofluorescence technique as reported previously [7] . The antigen was prepared from unfractionated P carinii washings and contained cysts and trophozoites. Sera were tested at dilutions ranging in two-fold steps from 1 in 8 to 1 in 256 for IgG antibodies and from 1 in 8 to 1 in 32 for IgM and IgA antibodies with fluorescein-labelled sheep anti-human IgG, IgM and IgA (Scottish Antibody Production Unit, Carluke).
SDS-PAGE and immunoblotting
Antigens were boiled for 5 min in a lysis buffer containing SDS 2%, 0.06 M Tris-HC1 (pH 6.8), 2-mercapto-ethanol 5%, glycerol 10% and bromophenol blue 0.001%. Electrophoresis was performed at a constant current of 6 mA for 16 h with a stacking 3.5% gel and a separating 12% slab gel in a discontinuous SDS buffer system. A mol. wt standard mixture containing myosin, P-galactosidase, phosphorylase B, bovine albumin, egg albumin and carbonic anhydrase (SDS6H; Sigma) was run on each gel. Separated proteins were transferred to nitrocellulose sheets (pore size 0.45 pm) in an LKB 2005 electroblotting unit at 4°C for 2 h at 0.8 A. Lanes containing the mol. wt standards were stained with amido black (Sigma) and used as standards to determine the mol. w t s of test proteins. The remainder of the sheet was blocked in PBS containing non-fat milk 5% for 1 h, rinsed in PBS containing Tween 20 0.05% (PBST), dried and stored in the dark at room temperature. Strips cut from the sheet were incubated for 16 h at room temperature with a 1 in 100 or 1 in 500 dilution of serum for IgG and 1 in 50 dilution of serum for IgM and IgA in PBST containing non-fat milk 5% (PBSN). Strips were washed five times in PBST, then incubated for 2 h at room temperature in a 1 in 1000 dilution of goat anti-human IgG, IgM or IgA peroxidase conjugate (Sigma) in PBSN. After five washes in PBST and two in PBS, strips were immersed in substrate (4-chloro-lnapthol 0.006% in methanol, H202 0.014% in PBS) for 10 min, washed twice in PBST, once in distilled water, left for 30min in distilled water and dried.
Statistical analysis
Where appropriate, data were subjected to statistical analysis by x2 with Yates' correction for small samples.
Results
IgG immunoblotting
When 17 blood donor and 14 patient sera were tested at a 1 in 100 dilution, cyst-rich antigen produced weak bands in the 50-60-kDa range whereas trophozoite-rich antigen produced a range of bands. As trophozoite antigen was the more reactive, it was used for immunoblotting and cyst antigen was not pursued. With blood donor sera tested at a 1 in 100 dilution, a range of bands was demonstrated. A broad band between 50 and 60kDa was dominant and present in 24 of 48 sera. Just 6 of 48 blood donor sera were immunoblot-negative; only 3 of 28 of these sera showed specific IgG antibody to I? carinii by IFA and only at a titre of 1 in 8. Eighteen sera from blood samples taken for therapeutic purposes showed a similar pattern of reactivity. When four of these control sera were tested at dilutions of 1 in 100, 1 in 200, 1 in 400 and 1 in 500, bands >70kDa were virtually eliminated and the intensity of bands at 50-60 kDa was reduced. This pattern was confirmed by repeat testing of 16 selected blood donor sera which were reactive at dilutions of 1 in 100 and 1 in 500 (Table 1) . All sera were subsequently tested at a 1 in 500 dilution to eliminate background antibody.
The major IgG bands detected in trophozoite-rich IT carinii antigen with patient sera are shown in Table 1 and Figs. 1 and 2 . Between one and eight prominent IgG immunoblotting bands were demonstrated. The intensity of the bands was variable and patterns were often weaker in patients with likely PCP than in patients with possible PCP (Figs. 1 and 2 ). There was no significant difference in the number of bands demonstrated by sera in the two patient groups Q2, p >0.5). Antibody to the 82-kDa protein was more common in patients with likely PCP. The band was demonstrated in 15 (50%) of 30 sera from patients with likely PCP compared with 15 (38%) of 39 sera from patients with possible PCP. Although this difference was not significant k2, p > O.l), this may be because of the small number of patients. There was also no significant difference in the frequency of detection of the 50-60-, 61-, 70-, 95-or 99-kDa bands in patients with likely and possible PCP k2, p > 0.5). The 116-kDa band was identified more frequently k2, p < 0.02) in sera from patients with possible PCP.
Patients' sera had IgG IFA titres from <8 to 256. Eighteen of 30 sera from patients with likely PCP were seropositive ( 3 16) by IgG IFA and three patients seroconverted. Thirty-four of 39 sera from patients with possible PCP were seropositive by IgG IFA. There was no significant difference in IgG IFA titres between patients with likely and possible PCP k2, pB0.5). Sera with higher IFA titres were more likely to be immunoblot positive k2, p < 0.02); 14 (56%) of 25 sera with IFA titres d 16 were immunoblot positive compared with 11 (65%) of 17 with IFA titres of 32 and 26 (96%) of 27 with higher titres.
The IgG IFA titres and immunoblotting patterns in sera from individual patients with likely PCP are shown in Table 2 
IgM and IgA
The 10 blood donor sera were IgA and IgM negative by IFA and immunoblotting. Patients' sera had IgA and IgM titres of <8-32 in the IFA. Sera demonstrating IgM or IgA immunoblotting bands, or both, recognised the same range of proteins as IgG, but the patterns were weaker. In four of 10 patients with likely PCP, two sera demonstrated IgM and IgA, three IgM only and one IgA only. In six of 15 patients with possible PCP, two sera demonstrated both IgM and IgA, six IgM only and none IgA only. Sera with IFA titres of 8 produced between two and six bands on blotting. All the sera that demonstrated IgA and IgM bands on blotting had IgG, IgM and IgA IFA titres 3 8.
Discussion
The need for a serological test for PCP has long been acknowledged [2, 4, 11, 121 and has been emphasised The IgG immunoblotting patterns of sera from patients with likely and possible PCP were similar, but significantly different from blood donor sera. Antibody to 50-60-, 61-, 70-, 82-, 95-, 99-and 116-kDa proteins was present in patients' sera whereas only the 50-60-kDa protein was demonstrated in control sera. This accords well with the antibody to 50-60-, 63-, 81-, 104-and 124-kDa proteins found in sera from immunosuppressed rats with PCP [ lo]. In patients' sera, the 61-kDa protein, (probably equivalent to the rat 63-kDa protein) was equally recognised by both patient groups, but antibody to the 82-kDa protein, (equivalent to the rat 81-kDa protein) was most prominent in patients with likely PCP; this may be a useful marker of current infection. Like other studies [ 121, this study found variability in blotting patterns, and sera from patients with likely PCP sometimes produced weaker and fewer bands than sera from patients with possible PCP By testing sera at a high dilution to eliminate background antibody, detection of low levels of antibody in these immunosuppressed patients may have been compromised.
The 116-kDa protein probably represents the major surface glycoprotein (MSG) of rat-derived r! carinii [2, 41. This protein is by far the best studied and has been cloned and sequenced [l, 21 . It has been suggested that the equivalent human-derived rl carinii protein would be useful in serology [2, 41 , but this laboratory found that antibody to rat MSG was of limited use, as it was more prominent in patients with possible than likely I! carinii pneumonia. This is perhaps not surprising as trophozoite antigen was found to be more useful than cyst antigen and MSG is less abundant in trophozoites than cysts [16] . MSG gave variable results when used to characterise different human isolates with monoclonal antibodies, which may be useful in distinguishing isolates, but is a disadvantage in epidemiological studies [2] . In a major irnmunoblotting study Peglow et al. identified major immunoblotting bands of 40, 66, 92 and 116 kDa in human I! carinii; again, it was not the 116-kDa MSG which proved to be the major marker of I! carinii, but rather a 40-kDa protein. This study also confirmed the cross-reactivity of rat-derived and human-derived E! carinii antigens, as these major bands were detected when different human or rat isolates were tested, and when different serum specimens from human patients and rats were used as source antibody [12] . It is possible that the 82 kDa rat-derived E! carinii protein prominent in the present study is a variant of this 40-kDa human-derived I? carinii protein.
There is little published information on IgA testing for PCP [ 171. Active IgM responses to a 40-kDa antigen have been detected in PCP patients [12] , but this laboratory [7] and others [18, 191 by an IFA to detect cysts, but positive by PCR which detects cysts and trophozoites [21] . It is likely that the antibody response is to trophozoite antigens early in infection, and then broadens to include antibodies to antigens common to cysts and trophozoites. Thus, immunoblotting with trophozoite antigen may be more useful early in infection when trophozoites predominate and antibody levels are low, and IFA may be more appropriate later in infection to detect antibody to both cysts and trophozoites. The results described in this paper confirm both the usefulness of ratderived antigen in serological diagnosis of PCP [5-81 and the importance of trophozoite antigens in the future development of PCP serology.
